/C O R R E C T I O N -- BillionToOne/
BillionToOne announced the publication of a prospective study in Obstetrics & Gynecology involving 2,212 general-risk pregnancies, which demonstrated that its Unity Fetal Risk Screen achieved 94.4% sensitivity and 99.5% specificity. The study is the first of its kind conducted in an intended-use screening population, showing that cfDNA fetal risk assessment identifies more affected pregnancies than traditional carrier screening, which often misses cases due to incomplete partner testing.
Key figures
- Sensitivity
- 94.4%
- Specificity
- 99.5%
- Study participants
- 2212
- New panel gene count
- 130
- Outcome completion rate
- 98.6%
- Negative predictive value
- >99.9%
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.